carbapenems has been researched along with Cerebral Ventriculitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liu, Y; Wang, H; Wu, G; Xu, X | 1 |
| Chusri, S; Doi, Y; Kositpantawong, N; Panthuwong, S; Pattharachayakul, S; Sakarunchai, I; Santimaleeworagun, W; Singkhamanan, K | 1 |
| Cleveland, KO; Gelfand, MS | 1 |
3 other study(ies) available for carbapenems and Cerebral Ventriculitis
| Article | Year |
|---|---|
Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Central Nervous System Infections; Cerebral Ventriculitis; Encephalitis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Tigecycline | 2022 |
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Anti-Bacterial Agents; Blood-Brain Barrier; Carbapenems; Cerebral Ventriculitis; Colistin; Female; Humans; Injections, Intraventricular; Injections, Spinal; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Surgical Wound Infection | 2018 |
Successful treatment with doripenem of ventriculitis due to Achromobacter xylosoxidans.
Topics: Achromobacter denitrificans; Adult; Anti-Bacterial Agents; Carbapenems; Cerebral Ventriculitis; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Treatment Outcome | 2014 |